Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Keel Infrastructure Corp. Common Stock (KEEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Keel Infrastructure Corp. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.69 (market cap $6.04B), while Keel Infrastructure Corp. Common Stock trades at $3.06 (market cap $1.93B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 3.1× Keel Infrastructure Corp. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Keel Infrastructure Corp. Common Stock for 1 Days on average.
| IOVA | KEEL | |
|---|---|---|
Market Cap | $6.04B | $1.93B |
Volume | 14,805,993 | 30,868,523 |
Sector | Health | Technology |
52-Week High | $14.82 | $6.66 |
52-Week Low | $1.81 | $1.71 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $2.25B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Keel Infrastructure Corp. Common Stock
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →
